VORTEX is a randomised phase III trial concerning post-operative radiotherapy given to adult patients with extremity soft tissue sarcoma.
For copies of the latest and previous versions of documents distributed for this trial, please contact the Vortex Trial Office at VORTEX@trials.bham.ac.uk
VORTEX has two treatment arms comparing a two-phase conventional radiotherapy treatment with that of a single phase treatment to selectively spare normal tissue and increase limb function without compromising local control.